Novel BCMA-targeted CAR-T Cell Therapy for Multiple Myeloma
Conditions
- Relapsed or Refractory Multiple Myeloma
Interventions
- BIOLOGICAL: anti-BCMA CAR-T
- DRUG: Cyclophosphamid
- DRUG: Fludarabine
Sponsor
Second Affiliated Hospital, School of Medicine, Zhejiang University
Collaborators